AI and digital health are no longer side stories. They are changing how life sciences companies build, launch, sell, and scale.
This section tracks the technologies and the operating-model consequences that matter.
AI in Commercial Operations Agentic AI in Life Sciences Commercial: What Actually Changes in Your Operating Model Agentic AI is being sold into pharma commercial organisations that were never built for autonomous decisioning. The real question is not what agents can do, but what has to change in the operating model before any of that…
Every health AI model is a decision engine — and an attack surface. The Risks (with Evidence) Why Healthcare Is Special Framework for Defence Aligned with the EU AI Act’s high-risk obligations: risk management, logging, human oversight (European Commission). In healthcare, AI isn’t “just software” — it’s safety-critical infrastructure.
The Promise Pharma spends billions on R&D only to see 90% of drug candidates fail in trials. At the heart of the problem: chemistry is a quantum system, but we’ve been simulating it with classical approximations. Quantum computing, in principle, can simulate molecules and protein folding with physics-native precision, potentially cutting years and billions from discovery…
Quantum computing is the latest shiny object in healthcare IT. Headlines trumpet its ability to solve the unsolvable, to accelerate drug discovery, and to personalise medicine at a level classical AI can only dream of. The reality, however, is a little noisier, literally. In 2025, we are firmly in what researchers call the NISQ era….
What is Artificial Intelligence (AI) in a pharma marketing context? In a pharma commercial context, AI primarily refers to generative AI, which differs from traditional “classical AI” or machine learning. AI in Commercial Operations Agentic AI in Life Sciences Commercial: What Actually Changes in Your Operating Model Understanding AI in pharma marketing can significantly enhance…
Cancer detection has seen a revolutionary transformation, thanks to the emergence of a technique known as Protein Biomarker Analysis using Proximity Ligation Assays (PLA). This novel approach is a game changer in identifying cancer at its nascent stages, improving the chances of successful treatment and recovery. But what exactly is PLA, and how does it…
Digital health in 2023 continues to advance rapidly. Medical devices that utilize digital technology are becoming increasingly popular and offer a wide range of benefits, including improved accuracy, increased convenience, and greater efficiency. In this post, we’ll take a look at the top 10 medical devices revolutionizing digital health in 2023. Smart Inhalers Smart inhalers…
This Series B round of funding for the startup was led by Cigna Ventures and 7wireVentures, with participation from Longitude Capital, Kaiser Permanente Ventures, F-Prime Capital, Eight Roads Capital, and Health Enterprise Partners. It brings the total funding of NOCD to $84M. NOCD – Company Overview NOCD is the world’s leading provider of treatment for…
Coronavirus COVID-19 (NCov-2019) has tested some of the digital health capabilities such as AI-based predicitive models and real-time big data visualization. As a positive side effect, it has also allowed public to learn about epidemiology via video games. AI-based predictive models caught COVID-19 faster than us According to the news reports, two AI-based and…
Lions Healthcare 2016 Awards for the best pharmaceutical advertising have been announced. See the winners. As every year, what they show is that pharma advertising lacks creativity. What is more important, 2016 Lions Healthcare Pharma winners are not those most efficient in conveying the message and changing prescription behaviors.Lions Healthcare is a contest made by agencies…